Form 4: FibroBiologics CEO Pete O'Heeron Buys 8,500 Shares of Common Stock
SEC Form 4 Filing
FibroBiologics CEO Pete O'Heeron acquired 8,500 shares of the company's common stock at an average price of $1.914 on August 12, 2024.
Summary
- On August 12, 2024, Pete O'Heeron, the CEO of FibroBiologics, Inc. purchased 8,500 shares of common stock.
- The shares were bought at a weighted average price of $1.914.
- The transactions ranged from $1.82 to $2.017 per share.
- Following the transaction, O'Heeron directly owns 6,056,647 shares of FibroBiologics.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the CEO's purchase of shares, which can be interpreted as a sign of confidence in the company's future.
Positives
- The CEO's purchase of shares could be interpreted as a positive signal about the company's prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued.
Stakeholder Impact
- The CEO's stock purchase could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/12/2024 | Date of the transaction: Pete O'Heeron purchased 8,500 shares of FibroBiologics common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.